Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01101984 ↗

Completed 400 enrolled Santen Pharmaceutical Co., Ltd.

RandomizedParallel-groupSingle-blindTreatment

Summary

Safety and efficacy of DE-089 ophthalmic solution in patients with dry eye will be evaluated in comparison with sodium hyaluronate ophthalmic solution.

Timeline

Start: 2010-02
Primary completion: —
Completion: 2012-04

Publications

Gong L, Sun X, Ma Z, Wang Q, Xu X, Chen X, Shao Y, Yao K, Tang L, Gu Y, Yuan H, Chua WH, Chuan JC, Tong L. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore. Br J Ophthalmol. 2015 Jul;99(7):903-8. doi: 10.1136/bjophthalmol-2014-306084. Epub 2015 Jan 28.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diquafosol	Oligonucleotide (other)	3 %	Topical
Subject	Sodium Hyaluronate	Other / unclassified	0.1 %	Topical

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

Summary

Timeline

Publications

Drugs

Indications